Pfizer Inc. (NYSE: PFE) Q2 2021 Earnings call dated Jul. 28, 2021
Corporate Participants:
Christopher Stevo — Senior Vice President, Chief Investor Relations Officer
Albert Bourla — Chairman and Chief Executive Officer
Mikael Dolsten — Chief Scientific Officer and President, Worldwide Research, Development and Medical
Frank DAmelio — Chief Financial Officer
Angela Hwang — Group President, Pfizer Biopharmaceuticals Group
Analysts:
Kerry Holford — Berenberg — Analyst
Matthew Harrison — Morgan Stanley — Analyst
Daniel Bisbee — RBC Capital — Analyst
Chris Schott — J.P. Morgan — Analyst
Ronny Gal — Bernstein — Analyst
Geoff Meacham — Bank of America — Analyst
Andrew Baum — Citi — Analyst
Carter Gould — Barclays — Analyst
Geoffrey Porges — SVB Leerink — Analyst
Louise Chen — Cantor — Analyst
Terence Flynn — Goldman Sachs — Analyst
_________
To read the full earnings call transcript, click here
Most Popular
UAL Earnings: Highlights of United Airlines’ Q1 2025 financial results
Aviation giant United Airlines Holdings, Inc. (NYSE: UAL) on Tuesday announced financial results for the first quarter of 2025. Net income, on an adjusted basis, was $0.91 per share in
Earnings Preview: Will Tesla’s Q1 2025 earnings signal a turnaround?
Tesla Inc. (NASDAQ: TSLA) is preparing to report first-quarter results amid expectations for a mixed outcome. The company has been going through a rough patch for some time, with slowing
What to look for when Southwest Airlines (LUV) reports Q1 2025 earnings results
Shares of Southwest Airlines Co. (NYSE: LUV) were up over 2% on Tuesday. The stock has dropped 21% over the past three months. The airline is scheduled to report its
Listen On
